Rapid response of cutaneous lupus erythematosus to treatment with the type 1 interferon receptor antagonist anifrolumab

被引：1
|
作者：
Guenther, Claudia [1 ]
机构：
[1] Tech Univ Dresden, Dept Dermatol, Univ Med Ctr Hosp, Dresden, Germany
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 02期
关键词：
SIGNATURE;
D O I：
10.1093/bjd/ljad111
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：151 / +
页数：2
相关论文
共 50 条
  • [21] Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus
    Joerg Wenzel
    Sabine Zahn
    Thomas Bieber
    Thomas Tüting
    Archives of Dermatological Research, 2009, 301 : 83 - 86
  • [22] Subacute cutaneous lupus erythematosus associated with interferon beta-1a
    Nousari, HC
    Kimyai-Asadi, A
    Tausk, FA
    LANCET, 1998, 352 (9143): : 1825 - 1826
  • [23] Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus
    Wenzel, Joerg
    Zahn, Sabine
    Bieber, Thomas
    Tueting, Thomas
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 83 - 86
  • [24] Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus
    Shaw, Katharina
    Sanchez-Melendez, Stephanie
    Taylor, Dustin
    Barker, Julia
    LaChance, Avery
    Shahriari, Neda
    Vleugels, Ruth Ann
    JAMA DERMATOLOGY, 2023, 159 (05) : 560 - 563
  • [25] Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1) a randomised, controlled, phase 3 trial
    Furie, Richard A.
    Morand, Eric F.
    Bruce, Ian N.
    Manzi, Susan
    Kalunian, Kenneth C.
    Vital, Edward M.
    Ford, Theresa Lawrence
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip Z.
    Berglind, Anna
    Tummala, Raj
    LANCET RHEUMATOLOGY, 2019, 1 (04): : E208 - E219
  • [26] Rapid Efficacy of Anifrolumab Across Multiple Subtypes of Recalcitrant Cutaneous Lupus Erythematosus Parallels Discrete Changes in Transcriptomic and Cellular Biomarkers
    Carter, Lucy Marie
    Wigston, Zoe
    Arnold, Jack
    Laws, Philip
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1923 - 1924
  • [27] Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review
    Khan, Muhammad Atif
    Khan, Faiza Humayun
    Khan, Hina Benish
    Saadeh, Constantine
    Davey, Nichole
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [28] Response to antimalarials in cutaneous lupus erythematosus
    Chang, A. Y.
    Piette, E. W.
    Foering, K. P.
    Tenhave, T. R.
    Okawa, J.
    Werth, V. P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S80 - S80
  • [29] Drug-induced subacute cutaneous lupus erythematosus due to treatment with interferon beta-1a
    Buchanan, Sarah
    Rosemergy, Ian
    Healy, Paul
    NEW ZEALAND MEDICAL JOURNAL, 2013, 126 (1379) : 98 - 101
  • [30] Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment
    Shaw, Katharina S.
    Reusch, Diana B.
    Castillo, Rochelle L.
    Hashemi, Kimberly B.
    Sundel, Robert
    Dedeoglu, Fatma
    Vleugels, Ruth Ann
    JAMA DERMATOLOGY, 2024, 160 (02) : 237 - 238
12345